XML 23 R8.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consolidated Statements of Cash Flows - USD ($)
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Cash flows from operating activities:      
Net income (loss) $ 10,279,000 $ (594,732,000) $ 39,132,000
Adjustments to reconcile net income (loss) to net cash provided by operating activities:      
Depreciation and amortization 238,769,000 238,968,000 231,447,000
Provision for expected credit losses (2,700,000) 3,700,000 1,050,000
Amortization of debt issuance costs 9,765,000 8,402,000 7,607,000
Unit-based compensation expense 15,523,000 8,400,000 10,814,000
Deferred income tax expense (benefit) (42,000) 530,000 1,376,000
Loss (gain) on disposition of assets (2,588,000) 146,000 940,000
Impairment of compression equipment 5,121,000 8,090,000 5,894,000
Impairment of goodwill 0 619,411,000 0
Changes in assets and liabilities, net of effects of business combination:      
Accounts receivable and related party receivables, net 145,000 23,542,000 (5,657,000)
Inventories (12,592,000) (11,682,000) (25,137,000)
Prepaid expenses and other current assets (3,572,000) (248,000) (604,000)
Other assets 3,489,000 3,167,000 2,589,000
Accounts payable 9,023,000 (3,745,000) (5,764,000)
Accrued liabilities and deferred revenue (5,195,000) (10,744,000) 36,901,000
Other liabilities 0 (7,000) (8,000)
Net cash provided by operating activities 265,425,000 293,198,000 300,580,000
Cash flows from investing activities:      
Capital expenditures, net (45,213,000) (109,070,000) (171,149,000)
Proceeds from disposition of property and equipment 4,466,000 2,647,000 22,478,000
Proceeds from insurance recovery 1,559,000 1,324,000 4,181,000
Net cash used in investing activities (39,188,000) (105,099,000) (144,490,000)
Cash flows from financing activities:      
Proceeds from revolving credit facility 697,679,000 777,472,000 852,265,000
Proceeds from issuance of senior notes 0 0 750,000,000
Payments on revolving credit facility (655,147,000) (706,384,000) (1,499,090,000)
Cash paid related to net settlement of unit-based awards (3,174,000) (1,125,000) (1,714,000)
Deferred financing costs (9,960,000) (3,875,000) (13,679,000)
Other (558,000) (772,000) (1,035,000)
Net cash used in financing activities (226,239,000) (188,107,000) (156,179,000)
Decrease in cash and cash equivalents (2,000) (8,000) (89,000)
Cash and cash equivalents, beginning of year 2,000 10,000 99,000
Cash and cash equivalents, end of year 0 2,000 10,000
Supplemental cash flow information:      
Cash paid for interest, net of capitalized amounts 120,564,000 120,729,000 105,356,000
Cash paid for income taxes 819,000 633,000 493,000
Supplemental non-cash transactions:      
Non-cash distributions to certain common unitholders (DRIP) 1,775,000 1,901,000 997,000
Transfers from inventories to property and equipment 10,793,000 17,435,000 21,822,000
Change in capital expenditures included in accounts payable and accrued liabilities 720,000 (8,557,000) 3,408,000
Financing costs included in accounts payable and accrued liabilities 391,000 115,000 18,000
Conversion of Class B Units to common units 0 0 67,302,000
Common units      
Cash flows from financing activities:      
Cash distributions (206,329,000) (204,673,000) (194,176,000)
Preferred Units      
Cash flows from financing activities:      
Cash distributions $ (48,750,000) $ (48,750,000) $ (48,750,000)